Cargando…

Editorial: Biomarkers of Brain Damage – A Complex Challenge With Great Potential

Detalles Bibliográficos
Autores principales:	Tenovuo, Olli, Janigro, Damir, Sanchez, Jean-Charles, Undén, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012542/ https://www.ncbi.nlm.nih.gov/pubmed/33815264 http://dx.doi.org/10.3389/fneur.2021.664445

Ejemplares similares

GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask
por: Janigro, Damir, et al.
Publicado: (2022)

Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
por: Janigro, Damir, et al.
Publicado: (2021)

Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
por: Janigro, Damir, et al.
Publicado: (2020)

Randomized Controlled Trials of Rehabilitation Services in the Post-acute Phase of Moderate and Severe Traumatic Brain Injury – A Systematic Review
por: Røe, Cecilie, et al.
Publicado: (2019)

Volume Change in Frontal Cholinergic Structures After Traumatic Brain Injury and Cognitive Outcome
por: Östberg, Anna, et al.
Publicado: (2020)

Great Challenges to Sleep Medicine: Problems and Paradigms
por: Pandi-Perumal, S. R., et al.
Publicado: (2010)

Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury
por: Lagerstedt, Linnéa, et al.
Publicado: (2020)

Trajectories of interleukin 10 and heart fatty acid-binding protein levels in traumatic brain injury patients with or without extracranial injuries
por: Niiranen, Toni J. U., et al.
Publicado: (2023)

Editorial: Potential biomarkers in neurovascular disorders
por: Xu, Yuzhen, et al.
Publicado: (2023)

Editorial: Moyamoya disease – natural history and therapeutic challenges
por: Svedung Wettervik, Teodor, et al.
Publicado: (2023)

Editorial: Anesthetic neurotoxicity in developing brains: mechanisms, biomarkers, and therapeutic targets
por: Yu, Yang, et al.
Publicado: (2023)

Editorial: Biomarkers in Neurology
por: Mondello, Stefania, et al.
Publicado: (2020)

Editorial: Complex Scenarios of Drug-Resistant Epilepsies: Diagnostic Challenges and Novel Therapeutic Options
por: Didato, Giuseppe, et al.
Publicado: (2022)

Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury
por: Hossain, Iftakher, et al.
Publicado: (2020)

Biomarkers in traumatic brain injury (TBI): a review
por: Dadas, Aaron, et al.
Publicado: (2018)

Cerebral Microbleeds and Structural White Matter Integrity in Patients With Traumatic Brain Injury—A Diffusion Tensor Imaging Study
por: Dahl, Juho, et al.
Publicado: (2022)

“Omics” in traumatic brain injury: novel approaches to a complex disease
por: Abu Hamdeh, Sami, et al.
Publicado: (2021)

Editorial: Biomarkers for stroke recovery
por: Kumar, Pradeep, et al.
Publicado: (2023)

Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases
por: Hu, Chaur-Jong, et al.
Publicado: (2019)

Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury
por: Posti, Jussi P., et al.
Publicado: (2020)

Editorial: Lipids in the Brain
por: Albi, Elisabetta, et al.
Publicado: (2020)

Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
por: Murcko, Robert, et al.
Publicado: (2022)

Editorial: Current Challenges in Cardioembolic Stroke
por: Fuentes, Blanca, et al.
Publicado: (2021)

Editorial: Biomarkers in migraine beyond diagnosis
por: Chen, Zhiye, et al.
Publicado: (2022)

Editorial: Biomarkers in neurology, volume II
por: Mohamed, Wael M. Y., et al.
Publicado: (2023)

Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers
por: Dadas, Aaron, et al.
Publicado: (2016)

Editorial: Biomarkers of neurodegeneration and brain function and their relationships with clinical and neuropsychological outcomes in monitoring deep brain stimulation efficacy in movement disorder patients
por: González-Rosa, Javier J., et al.
Publicado: (2022)

Editorial: Hyperbaric oxygen and the brain
por: Hadanny, Amir, et al.
Publicado: (2022)

Editorial: Challenges in Posterior Circulation Ischemic Stroke
por: Puetz, Volker, et al.
Publicado: (2021)

Editorial: Challenges in Acute Minor Ischemic Stroke
por: Heldner, Mirjam R., et al.
Publicado: (2022)

Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis
por: Blaabjerg, Morten, et al.
Publicado: (2019)

Editorial: Advanced Neuroimaging of Brain Metastases
por: Vachha, Behroze A., et al.
Publicado: (2021)

Editorial: Predictive Imagable Biomarkers for Neurodegenerative and Neurodevelopmental Diseases
por: Mandal, Pravat K., et al.
Publicado: (2019)

Editorial: Biomarkers and Clinical Indicators in Motor Neuron Disease
por: Bede, Peter, et al.
Publicado: (2019)

Editorial: The Pupil: Behavior, Anatomy, Physiology and Clinical Biomarkers
por: Zele, Andrew J., et al.
Publicado: (2020)

Editorial: Tuberous Sclerosis Complex – Diagnosis and Management
por: Jozwiak, Sergiusz, et al.
Publicado: (2021)

The role of the blood–brain barrier during neurological disease and infection
por: Patabendige, Adjanie, et al.
Publicado: (2023)

CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy
por: Nass, Robert Daniel, et al.
Publicado: (2021)

Editorial: Traumatic Brain Injury and Autoimmune Disease
por: Shively, Sharon Baughman, et al.
Publicado: (2021)

Editorial: Human brain banking – Bridging brain health and precision neurology
por: Huang, Yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0dhb2tc8nt9sp0tp2uccnagghb